Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Cerilliant
Citi
Mallinckrodt
Daiichi Sankyo
McKinsey
AstraZeneca
Express Scripts
Fish and Richardson

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202865

« Back to Dashboard
NDA 202865 describes AMPICILLIN SODIUM, which is a drug marketed by Istituto Bio Ita Spa, Watson Labs Inc, Mylan Labs Ltd, Intl Medication, Consolidated Pharm, Sandoz, Hanford Gc, Antibiotice, Apothecon, Hospira Inc, Lilly, Sagent Pharms, Acs Dobfar Spa, West-ward Pharms Int, and Aurobindo Pharma, and is included in thirty-two NDAs. It is available from seventeen suppliers. Additional details are available on the AMPICILLIN SODIUM profile page.

The generic ingredient in AMPICILLIN SODIUM is ampicillin sodium. There are sixty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.

Summary for NDA: 202865

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 202865

Ingredient-typePenicillins

Suppliers and Packaging for NDA: 202865

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMPICILLIN SODIUM
ampicillin sodium
INJECTABLE;INJECTION 202865 ANDA Hospira, Inc. 0409-2686 0409-2686-01 10 BOTTLE in 1 CARTON (0409-2686-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE (0409-2686-11)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10GM BASE/VIAL
Approval Date:Sep 4, 2015TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Express Scripts
Cipla
Fuji
Citi
Chinese Patent Office
Cerilliant
Federal Trade Commission
Queensland Health
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot